维普期刊资源整合服务平台（V6.5）

396篇 您的检索式：作者名="MANEGOLD C"

选中清除导出查看参考文献查看引证文献引用追踪共20页首页上一页第1页下一页末页 /20 跳转

	题名	作者	年代	出处	被引量
1	Treatment of elderly patients with non-small cell lung cancer 显示文摘	Manegold C	2001	Oncology (Hungtingt)2001，15，6：	1
2	Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: A phase Ⅲ trial-INTACT1 显示文摘	Giaccone G Herbst RS Manegold C	2004	J Clin Oncol2004，22，5：	1
3	Gemcitabine in non-small-cell lung cancer显示文摘	Manegold C Zatloukal P Krejcy k	2000	Invest New Drugs2000，18，1：	1
4	Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer:a phase Ⅲ trial 2 intact1显示文摘	Giaccone G Herbst RS Manegold C	2004	J Clin Oncol2004，22，9：	1
5	Gemcitabine in non-small cell lung cancer(NSCLC) 显示文摘	Manegold C Zatloukal P Krejcy K	2000	Invest New Drugs2000，18，1：	1
6	Bevacizumab for the treatment of advanced non-small-cell lung cancer显示文摘	Manegold C		0，，：	1
7	Gemcitabine(Gemzar) in non-small cell lung cancer显示文摘	Manegold C	2004	Expert Rev Anticancer Ther2004，4，3：	1
8	Gefitinib in corn hination with gemcitabine and cisplatin in advanced non-small cell lung cancer:a phase III trial--INTACT 1显示文摘	Giaccone G Herbst RS Manegold C	2004	J Clin On- col2004，22，5：	1
9	Front - line treatment of advancednon - small - cell lung cancer with MTA ( LY231514, pemetrexed disodium, ALIMTA) andcisplatin : a mul- ticenter phase II trial显示文摘	Manegold C Gatzemeier U von Pawel J	2000	Ann Onco12000，11，4：	1
10	Randomized phase 1I trial of a toll-like receptor 9 agonist oligodeoxynucleotide, PF-3512676, in combination with first-line taxane plus platinum chemotherapy for advanced-stage non-small-cell lung cancer显示文摘	Manegold C Gravenor D Woytowitz D	2008	J Clin Oncol2008，26，24：	1
11	Front-line treatment of advanced non-small-cell lung cancer with MTA (LY231514,pometrexed disodium,ALIMTA) and cisplatin:a multicenter phase Ⅱ trial显示文摘	Manegold C Gatzemeier U Von Pawel J	2000	Ann Oncol2000，11，4：	1
12	Raltitrexed (Tomudex) and cisplatin in metastatic non-small cell lung cancer (NSCLC) : peliminary results of a Phase Ⅰ dose-escalation study 显示文摘	Manegold C Buchholz E Kloeppel R	1999	Eur J Cancer1999，35，4：	1
13	Randomized phase Ⅲ trial of gemcitabine/cisplatin with or without PF-3512676 as first line treatment of advanced non-small cell lung cancer (NSCLG) 显示文摘	Manegold C Thatcher N Benner R J	2008	J Clin Oncol2008，26，：	1
14	Short - term treatment - related symptoms and quality of life: results from an international randomized phase III study of cispla- tin with or without raltitrexed in patients with malignant pleural mesothelioma: an EORTC Lung - Cancer Group and National Cancer Institute, Canada, Intergroup Study 显示文摘	Bottomley A Gaafar R Manegold C	2006	J Clin Oneol2006，24，9：	1
15	Phase Ⅱ study of two dose schedules of CERA ( continuous erythropoietin receptor activator ) in anemic patients with advanced non-small cell lung cancer (NSCLC) receiving chemotherapy显示文摘	Hirsh V Glaspy J Mainwaring P Manegold C Ramlau R Eid JE	2007	Trials2007，8，：	1
16	Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer:a phase III trial--INTACT 1显示文摘	HERBST RS MANEGOLD C	2004	J Clin Oncol2004，22，5：	1
17	C,efitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer:A phase Ⅲ trial-INTACT 1显示文摘	Giaccone G Herbst RS Manegold C	2004	J Clin Oncol2004，22，：	1
18	Gemcitabine (Gemzar) in non -small cell lung cancer 显示文摘	Manegold C	2004	Expert Rev Anticancer Ther2004，4，3：	1
19	Gefitinib in com- bination with gemcitabine and cisplatin in advanced non-small-cell lung cancer:A phase Ⅲ trial INTACT 1 显示文摘	Giaccone G herbst RS Manegold C	2004	J Clin Oncol2004，22，5：	1
20	Randomized phase Ⅲ study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada 显示文摘	van Meerbeeck JP Gaafar R Manegold C	2005	J Clin Oncol2005，23，28：	1

返回顶部每页显示：

共20页首页上一页第1页下一页末页 /20 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示